Vise Technologies’s Globus Medical GMED Stock Holding History

Vise Technologies’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739K	Hold	8,469	–	–	0.01%	693
2025 Q4	$739K	Buy	+8,469	New	+$643K	0.01%	698

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vise Technologies's GMED Position: Q1 2026 in Review

Vise Technologies held its Globus Medical (GMED) position steady in Q1 2026 at 8,469 shares worth $739K. The position accounts for 0.01% of the portfolio, ranked #693.

Vise Technologies first reported a position in GMED in Q4 2025 and has held it in 2 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Vise Technologies held 8,469 shares of Globus Medical worth $739K as of Q1 2026.
Vise Technologies left its Globus Medical share count unchanged in Q1 2026.
Globus Medical made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #693 holding.
Vise Technologies first reported a position in Globus Medical in Q4 2025 and has held it in 2 quarters since.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.